Pillar Pacific Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$6.53M Buy
101,008
+2,140
+2% +$138K 0.51% 73
2020
Q4
$5.76M Sell
98,868
-312
-0.3% -$18.8K 0.48% 78
2020
Q3
$6.27M Buy
99,180
+215
+0.2% +$14.9K 0.6% 62
2020
Q2
$7.61M Sell
98,965
-1,157
-1% -$88.7K 0.8% 42
2020
Q1
$7.49M Buy
100,122
+25
+0% +$1.73K 0.99% 32
2019
Q4
$6.5M Sell
100,097
-509
-0.5% -$33.1K 0.67% 59
2019
Q3
$6.38M Sell
100,606
-319
-0.3% -$20.9K 0.72% 54
2019
Q2
$6.82M Buy
100,925
+931
+0.9% +$61.2K 0.76% 50
2019
Q1
$6.5M Sell
99,994
-1,650
-2% -$110K 0.75% 52
2018
Q4
$6.36M Buy
101,644
+535
+0.5% +$37.4K 0.84% 45
2018
Q3
$7.81M Sell
101,109
-6,385
-6% -$482K 0.85% 39
2018
Q2
$7.62M Buy
107,494
+1,380
+1% +$97.5K 0.88% 40
2018
Q1
$8M Buy
106,114
+2,195
+2% +$174K 0.95% 35
2017
Q4
$7.45M Sell
103,919
-1,750
-2% -$133K 0.91% 42
2017
Q3
$8.56M Buy
105,669
+860
+0.8% +$65.8K 1.1% 23
2017
Q2
$7.42M Sell
104,809
-545
-0.5% -$36.3K 1.01% 27
2017
Q1
$7.16M Buy
105,354
+1,055
+1% +$74.2K 1.01% 27
2016
Q4
$7.47M Buy
104,299
+4,790
+5% +$356K 1.15% 18
2016
Q3
$7.87M Buy
99,509
+1,390
+1% +$113K 1.24% 10
2016
Q2
$8.18M Buy
98,119
+709
+0.7% +$62.9K 1.38% 5
2016
Q1
$8.95M Buy
97,410
+1,268
+1% +$114K 1.55% 2
2015
Q4
$9.73M Sell
96,142
-2,659
-3% -$277K 1.74% 1
2015
Q3
$9.7M Buy
98,801
+510
+0.5% +$56.6K 1.82% 1
2015
Q2
$11.5M Sell
98,291
-11,908
-11% -$1.3M 1.99% 1
2015
Q1
$10.8M Sell
110,199
-535
-0.5% -$54.3K 1.9% 1
2014
Q4
$10.4M Sell
110,734
-2,685
-2% -$278K 1.88% 1
2014
Q3
$12.1M Buy
113,419
+224
+0.2% +$21.9K 2.21% 1
2014
Q2
$9.38M Buy
113,195
+2,058
+2% +$160K 1.76% 1
2014
Q1
$7.87M Sell
111,137
-7,685
-6% -$603K 1.6% 1
2013
Q4
$8.92M Sell
118,822
-3,295
-3% -$229K 1.78% 1
2013
Q3
$7.68M Sell
122,117
-3,985
-3% -$238K 1.7% 1
2013
Q2
$6.46M Buy
+126,102
New +$6.57M 1.54% 1

Other funds holding GILD

Pillar Pacific Capital Management's GILD Position: Q1 2021 in Review

Pillar Pacific Capital Management increased its Gilead Sciences (GILD) stake by 2.2% in Q1 2021, buying an estimated $138K and bringing the position to 101,008 shares worth $6.53M. The position accounts for 0.51% of the portfolio, ranked #73.

Pillar Pacific Capital Management first reported a position in GILD in Q2 2013 and has held it in 32 quarters since. The position peaked at $12.1M in Q3 2014. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Pillar Pacific Capital Management held 101,008 shares of Gilead Sciences worth $6.53M as of Q1 2021.
  • Pillar Pacific Capital Management bought 2,140 Gilead Sciences shares in Q1 2021, an estimated $138K.
  • Gilead Sciences made up 0.51% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #73 holding.
  • Pillar Pacific Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 32 quarters since.
  • Pillar Pacific Capital Management's Gilead Sciences position peaked at $12.1M in Q3 2014.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.